tradingkey.logo

Helius Announces Positive Outcome Of The Portable Neuromodulation Stimulator Pons Stroke Registrational Program

ReutersJul 21, 2025 11:07 AM

- Helius Medical Technologies Inc HSDT.O:

  • HELIUS ANNOUNCES POSITIVE OUTCOME OF THE PORTABLE NEUROMODULATION STIMULATOR PONS® STROKE REGISTRATIONAL PROGRAM AND UPCOMING SUBMISSION TO FDA UNDER BREAKTHROUGH DESIGNATION

  • HELIUS MEDICAL TECHNOLOGIES INC - STUDIES CONFIRM MINIMAL ADVERSE EVENTS WITH PONS THERAPY

  • HELIUS MEDICAL TECHNOLOGIES: PLANNING TO FILE A SUBMISSION TO FDA FOR INDICATION IN STROKE DURING Q3 OF 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI